Authors:
SCHULER M
BRUNTSCH U
SPATHSCHWALBE E
SCHREZENMEIER H
PESCHEL C
FARBER L
BURGER KJ
LEISSNER J
HUBER C
AULITZKY WE
Citation: M. Schuler et al., LACK OF EFFICACY OF RECOMBINANT HUMAN INTERLEUKIN-6 IN PATIENTS WITH ADVANCED RENAL-CELL CANCER - RESULTS OF A PHASE-II STUDY, European journal of cancer, 34(5), 1998, pp. 754-756
Authors:
HEINZINGER M
WALLER CF
ROSENSTIEL A
SCHEID S
BURGER KJ
LANGE W
Citation: M. Heinzinger et al., QUALITY OF IL-3 AND G-CSF-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH EARLY CHRONIC PHASE CML, Leukemia, 12(3), 1998, pp. 333-339
Authors:
HOHAUS S
MARTIN H
WASSMANN B
EGERER G
HAUS U
FARBER L
BURGER KJ
GOLDSCHMIDT H
HOELZER D
HAAS R
Citation: S. Hohaus et al., RECOMBINANT HUMAN GRANULOCYTE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (G-CSF AND GM-CSF) ADMINISTERED FOLLOWING CYTOTOXIC CHEMOTHERAPY HAVE A SIMILAR ABILITY TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS, Bone marrow transplantation, 22(7), 1998, pp. 625-630
Citation: U. Haus et al., THE EFFECT OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER CHEMOTHERAPY OF VARIOUS TUMORS, Anti-cancer drugs, 8(6), 1997, pp. 597-602
Authors:
FARBER L
HAUS U
FUCHSEL G
THEML H
CHATSIPROIOS D
SCHMID H
BURGER KJ
DRECHSLER S
Citation: L. Farber et al., TREATMENT OF PROLONGED CHEMOTHERAPY-INDUCED SEVERE THROMBOCYTOPENIA WITH RECOMBINANT HUMAN INTERLEUKIN-3 - A REPORT ON 4 CASES, Anti-cancer drugs, 8(3), 1997, pp. 288-292
Authors:
WALLER CF
HEINZINGER M
ROSENSTIEL A
WINKLER J
BURGER KJ
MERTELSMANN R
LANGE W
Citation: Cf. Waller et al., TRANSPLANTATION OF PHILADELPHIA CHROMOSOME-NEGATIVE PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS IN EARLY CHRONIC PHASE CML AFTER MOBILIZATION WITH ICE-CHEMOTHERAPY FOLLOWED BY SIMULTANEOUS ADMINISTRATION OF RHIL-3 AND RHG-CSF OR OF RHC-CSF ALONE, Blood, 90(10), 1997, pp. 4587-4587
Authors:
HOHAUS S
MARTIN H
GOLDSCHMIDT H
HAUS U
FARBER L
BURGER KJ
HOELZER D
HAAS R
Citation: S. Hohaus et al., RECOMBINANT HUMAN GM-CSF OR RECOMBINANT HUMAN G-CSF FOR THE MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS - RESULTS OF A PROSPECTVE RANDOMIZED STUDY, Blood, 90(10), 1997, pp. 432-432
Authors:
WALLER CF
HEINZINGER M
FETSCHER S
BURGER KJ
MERTELSMANN R
LANGE W
Citation: Cf. Waller et al., PHILADELPHIA-CHROMOSOME NEGATIVE HEMATOPOIETIC PROGENITORS CAN BE MOBILIZED IN CML PATIENTS IN EARLY CHRONIC PHASE BY ICE CHEMOTHERAPY FOLLOWED BY SIMULTANEOUS ADMINISTRATION OF IL-3 AND G-CSF, Blood, 88(10), 1996, pp. 1623-1623
Citation: Kj. Burger et R. Dehner, ANTIHYPERTENSIVE EFFICACY AND TOLERABILIT Y OF ISRADIPINE IN PATIENTSWITH SEVERE HYPERTENSION-1 - RESULTS OF AN OPEN MULTICENTER STUDY, Arzneimittel-Forschung, 46(6), 1996, pp. 600-605
Authors:
BRUGGER W
RUMBERGER B
BERTZ H
FARBER L
BURGER KJ
MERTELSMANN R
KANZ L
Citation: W. Brugger et al., RANDOMIZED PHASE-II TRIAL OF HEMATOPOIETIC GROWTH-FACTOR SUPPORT (IL-3 PLUS GM-CSF VS IL-3 PLUS G-CSF) AFTER PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN PATIENTS WITH SOLID TUMORS AND LYMPHOMAS, Blood, 84(10), 1994, pp. 10000090-10000090
Authors:
SIMON A
MERLI I
DELPINO M
BRAUTIGAM M
WELZEL D
BURGER KJ
LEVENSON J
Citation: A. Simon et al., VASOSELECTIVE AND DRUG-SPECIFIC EFFECTS O F ISRADIPINE ON LARGE ARTERIAL VESSELS IN HYPERTENSIVE PATIENTS COMPARED TO METOPROLOL, Arzneimittel-Forschung, 44-1(3), 1994, pp. 305-309
Citation: Kj. Burger et M. Anlauf, CIRCADIAN ANTIHYPERTENSIVE EFFECTS OF ISR ADIPINE RETARD IN PATIENTS WITH ESSENTIAL-HYPERTENSION IN COMPARISON TO PLACEBO, Arzneimittel-Forschung, 43-2(9), 1993, pp. 958-962
Citation: Fw. Lohmann et al., CIRCADIAN ANTIHYPERTENSIVE EFFICACY AND T OLERABILITY OF A SLOW-RELEASE ISRADIPINE FORMULATION INTRAINDIVIDUALLY COMPARED WITH NITRENDIPINE, Arzneimittel-Forschung, 43-1(5), 1993, pp. 522-525